The “sobriety chip” is a subcutaneously implanted medical device designed to help individuals with severe alcohol dependence by delivering medication-assisted treatment. The chip, typically containing naltrexone (an alcohol inhibitor), is implanted under the skin of the abdomen and releases a steady dose of the drug into the bloodstream. Naltrexone blocks opioid receptors in the brain, reducing the pleasurable effects of alcohol and thereby diminishing cravings.This technology is primarily intended for severe addicts who have not responded to traditional abstinence methods. The implantation procedure requires only local anesthesia and takes approximately 15 minutes, with effects lasting several months. It is combined with psychological counseling and regular follow-ups to ensure efficacy and safety.Reports indicate that patients with 20-year alcohol addictions have successfully reduced both physical and psychological dependence, with significantly lower relapse rates. However, the technology must be used under strict medical supervision due to potential risks such as local infection or drug side effects, and it is not suitable for all individuals.
“戒酒芯片”是一种植入皮下的医疗装置，通过药物干预帮助重度酒精依赖者戒除酒瘾。其原理是将内含纳曲酮（一种酒精抑制剂）的微型芯片植入患者腹部皮下，芯片会持续、稳定地释放药物至血液。纳曲酮能阻断大脑中的阿片受体，减少饮酒带来的愉悦感，从而降低对酒精的渴求。该技术主要适用于传统戒酒方法无效的重度成瘾者。植入手术仅需局部麻醉，耗时约15分钟，芯片有效期可达数月。过程中需配合心理辅导与定期复查，以确保疗效与安全性。据报道，有20年酒瘾的患者在植入后逐渐摆脱对酒精的生理和心理依赖，复饮率显著降低。但该技术仍需严格遵循医嘱使用，可能存在局部感染或药物副作用风险，并非适用于所有人群。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/23007.html